MD Education are proud to introduce a new, virtual educational initiative for physicians and HCPs in IBD starting in January 2023 and running each month through to December 2023.

Each month, both chairs: Millie Long, MD and Raymond Cross, MD will meet with two leading IBD clinical experts to dive deep into the latest hot topics.

Each expert presentation will last around 20 minutes and will be accompanied by speaker slides that can be downloaded. Immediately following the presentations there will be a 15-20 minute Q&A session with the speakers and co-chairs.

Image hover effect image

Bio

Millie D. Long, MD

UNC School of Medicine

Image hover effect image

Bio

Raymond Cross, MD

University of Maryland

JANUARY

Management of Mental Health Disorders in Patients with IBD

Image hover effect image

Bio

Laurie Keefer

Icahn School Of Medicine, Mount Sinai, New York

Image hover effect image

Bio

Sara Horst

Vanderbilt IBD Clinic

FEBRUARY

Updates in Management of Perianal Crohn’s Disease

Image hover effect image

Bio

David Schwartz

Vanderbilt IBD Clinic

Image hover effect image

Bio

Amy Lightner

Cleveland Clinic

MARCH

Classification and Management of Pouch Disorders

Image hover effect image

Bio

Ed Barnes

UNC School of Medicine

Image hover effect image

Bio

Jami Kinnucan

Mayo Clinic, Florida

APRIL

Women’s Health in IBD: Preconception to Menopause

Image hover effect image

Bio

Uma Mahadevan

UCSF Colitis and Crohn’s Disease Center

Image hover effect image

Bio

Sonia Friedman

BWH Crohn’s & Colitis Center

WORLD IBD DAY | 19 May 2023

MAY

Health Maintenance in IBD

Image hover effect image

Bio

Frank Farraye

Mayo Clinic, Florida

Image hover effect image

Bio

Freddy Caldera

University of Wisconsin School of Medicine and Public Health

Medical & Surgical Approaches in Patients with Acute Severe Colitis

Image hover effect image

Bio

Neil Hyman

University of Chicago

Image hover effect image

Bio

Parambir Dulai

Northwestern Medicine

WORLD IBD DAY | 19 May 2023

MAY

Health Maintenance in IBD

Medical & Surgical Approaches in Patients with Acute Severe Colitis

Image hover effect image

Bio

Frank Farraye

Mayo Clinic, Florida

Image hover effect image

Bio

Freddy Caldera

University of Wisconsin School of Medicine and Public Health

Image hover effect image

Bio

Neil Hyman

University of Chicago

Image hover effect image

Bio

Parambir Dulai

University of Chicago

JUNE

Dysplasia Surveillance in Chronic Colitis: Who, when, how, and how often?

Image hover effect image

Bio

Samir Shah

Brown University

Image hover effect image

Bio

Kofi Clarke

Penn State College of Medicine

JULY

Post Operative Crohn’s Disease

Image hover effect image

Bio

Miguel Regueiro

Cleveland Clinic

Image hover effect image

Bio

Oriana Damas

University of Miami Health System

AUGUST

Positioning Highly Effective Therapy in CD

Image hover effect image

Bio

Alan C. Moss

Boston Medical Centre, Massachusetts

Image hover effect image

Bio

Meena Bewtra

Penn Medicine

SEPTEMBER

Positioning Highly Effective Therapy in UC

Image hover effect image

Bio

Gary Lichtenstein

Penn Medicine

Image hover effect image

Bio

Lisa Malter

NYU Grossman School of Medicine

OCTOBER

Classification and Management of Extraintestinal Manifestations

Image hover effect image

Bio

Florian Rieder

Cleveland Clinic

Image hover effect image

Bio

Kara De Felice

University of Cincinnati

NOVEMBER

Treat to Target and Therapeutic Monitoring in IBD

Image hover effect image

Bio

Steve Hanauer

Northwestern University

Image hover effect image

Bio

Marla Dubinsky

Icahn School Of Medicine, Mount Sinai, New York

CROHN’S & COLITIS AWARENESS WEEK | 1-7 December 2023

DECEMBER

Management of Refractory and Complicated Crohn’s Disease

Managing IBD from Pediatrics to the Elderly

Image hover effect image

Bio

Corey Siegel

The Dartmouth Institute for Health

Image hover effect image

Bio

Kim Isaacs

UNC School of Medicine

Image hover effect image

Bio

Mike Rosen

Stanford University

Image hover effect image

Bio

Bharati Kochar

Massachusetts General Hospital

CROHN’S & COLITIS AWARENESS WEEK | 1-7 December 2023

DECEMBER

Management of Refractory and Complicated Crohn’s Disease

Image hover effect image

Bio

Corey Siegel

The Dartmouth Institute for Health

Image hover effect image

Bio

Kim Isaacs

UNC School of Medicine

Managing IBD from Pediatrics to the Elderly

Image hover effect image

Bio

Mike Rosen

Stanford University

Image hover effect image

Bio

Bharati Kochar

Massachusetts General Hospital

Laurie Keefer-min (1)

Laurie Keefer

Icahn School Of Medicine, Mount Sinai, New York

Dr Laurie Keefer, PhD is a GI Health Psychologist and Professor of Medicine and Psychiatry at the Icahn School of Medicine at Mount Sinai in New York City.  She has a more than 20 years of experience in the development and implementation of behavioral therapies for chronic digestive disorders, including Inflammatory Bowel Disease (IBD). She currently directs the GRITT Program, an integrated care model for Crohn’s and ulcerative colitis patients within the IBD Center at Mount Sinai Hospital. She maintains a clinical practice focused on psychosocial concerns among medically complex IBD. 

Her NIH funded research portfolio focuses on the application of positive psychology principles, particularly resilience and acceptance to the management of chronic digestive conditions. She continues to focus on the development of precision-based, scalable GI self-management interventions and recently co-founded Trellus Health, Inc, a digital care solution for the chronic conditions based on her GRITT Methodology. 

Sara horst_10

Sara Horst

Vanderbilt IBD Clinic

Dr. Sara Horst MD, MPH, FACG is an Associate Professor in the division of Gastroenterology, Hepatology, & Nutrition at Vanderbilt University Medical Center. Dr. Horst completed her medical school and residency training at The Ohio State University and then went to Vanderbilt University Medical Center for Gastroenterology Fellowship and to obtain her Masters of Public Health. She joined the faculty at Vanderbilt University Medical Center in 2011 and specializes in the clinical care of patients with Inflammatory Bowel Disease. She is the Medical Director for VUMC Specialty Pharmacy, the Medical Director for Ambulatory Telehealth for VUMC, and the associate Vice Chair of Digital Health Operations for Department of Medicine. Her research interests involve psychosocial outcomes in IBD, medication adherence in IBD, and telehealth in IBD. She has extensively published in peer reviewed journals. She is also an Associate Editor for American Journal of Gastroenterology. 

Management of Mental Health Disorders in Patients with IBD

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

Laurie Keefer

Icahn School Of Medicine, Mount Sinai, New York

Sara Horst

Vanderbilt IBD Clinic

David Schwartz

David Schwartz

Vanderbilt IBD Clinic

David A. Schwartz, MD is a Professor of Medicine in the Division of Gastroenterology, Hepatology, and Nutrition at Vanderbilt University in Nashville, Tennessee.  He founded and currently serves as the Director of the Inflammatory Bowel Disease Center at Vanderbilt University Medical Center.

He received his postgraduate training at the Mayo Clinic in Rochester, Minnesota, where he completed a fellowship in Gastroenterology and Hepatology, and advanced training in Inflammatory Bowel Disease and Endoscopic Ultrasound.  He is a Fellow of the American College of Gastroenterology and the American Gastroenterological Association.

His editorial experiences include serving as a Section Editor for the IBD journal (2006-2014) , Associate Editor for Gastrointestinal Endoscopy (2014-2015), and served as the Select Summary Editor for Gastroenterology (2015-2022). His research has focused on clinical trials for inflammatory bowel disease, imaging of inflammatory -bowel disease, the multidisciplinary care of the IBD patient, and the treatment of perianal Crohn’s disease. He has lectured extensively throughout the United States and has written more than 300 articles, book chapters, and abstracts. 

Amy Lightner-min (1)

Amy Lightner

Cleveland Clinic

Amy Lightner is a Professor of Surgery in the Department of Surgery at Scripps Clinic in San Diego, CA and Chief Medical Office of Direct Biologics, LLC a biotechnology company in Regenerative Medicine. Dr. Lightner received her B.A. in Human Biology from Stanford University, completed her surgical training in General Surgery at University of California at Los Angeles and post-doctoral work at Stanford University under a California Institute of Regenerative Medicine Training Grant focused on the differentiation pathways of embryonic stem cells.  After completing her fellowship at Mayo Clinic, she stayed on as surgical faculty, and was the Medical Director for the Center for Regenerative Medicine at Mayo Clinic. She was then recruited to Cleveland Clinic as Associate Professor to focus on complex inflammatory bowel disease, continue her work in translational science and clinical trials, and start a regenerative medicine program. She founded, andwas medical director of the Center for Regenerative Medicine and Surgery at Cleveland Clinic Foundation, and continued her basic science research in stem cell therapy. She isthe PI of six active phase II clinical trials using mesenchymal stem cells for inflammatory bowel disease, has received extramural funding from the Helmsley Foundation, Crohn’s and Colitis Foundation, Cure for IBD, Rainin Foundation and American Society of Colon and Rectal Surgery (ASCRS).  She is a member of the editorial board of Inflammatory Bowel Diseases, Colorectal Disease, British Journal of Surgery, Crohn’s and Colitis 360, and Diseases of the Colon and Rectum, the surgical co-chair for the European Crohn’s and Colitis Organization annual meeting, the associate chair of the inflammatory bowel disease committee of ASCRS, vice chair of the national clinical practice guidelines committee for ASCRS, and chair of the surgical research committee for ASCRS.

Updates in Management of Perianal Crohn’s Disease

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

David Schwartz

Vanderbilt IBD Clinic

Amy Lightner

Cleveland Clinic

barnes.edward-min (1)

Edward L. Barnes

UNC School of Medicine

Edward L. Barnes, MD, MPH is an Assistant Professor of Medicine in the Division of Gastroenterology & Hepatology at the University of North Carolina at Chapel Hill. Dr. Barnes received his undergraduate and medical degrees from the University of South Carolina. He completed his internship, residency, and chief residency in internal medicine at the University of North Carolina. He completed his gastroenterology fellowship at Brigham and Women’s Hospital in Boston, Massachusetts. During his gastroenterology fellowship, Dr. Barnes received a Master of Public Health from the Harvard TH Chan School of Public Health. Following his gastroenterology fellowship, Dr. Barnes completed a one year advanced fellowship in inflammatory bowel disease at the University of North Carolina.

Dr. Barnes has a research interest in the epidemiology and clinical outcomes of patients with inflammatory bowel disease. He has a particular interest in improving our understanding of inflammatory conditions of the pouch after restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA). He has received funding from the Crohn’s & Colitis Foundation, American College of Gastroenterology, and the National Institutes of Health to study clinical outcomes of patients with pouchitis and other pouch-related conditions and to investigate predictors of a complicated disease course after IPAA. He was honored with the Sherman Emerging Leader Prize in 2021. 

Jami-Kinnucan-MD

Jami Kinnucan

Mayo Clinic, Florida

Jami Kinnucan, M.D. is an inflammatory bowel disease specialist and Senior Associate Consultant in the Division of Gastroenterology and Hepatology at the Mayo Clinic in Jacksonville, FL. She currently serves as the Clinical Practice Chair for the Division of Gastroenterology & Hepatology and Co-Director for Digital Health and Practice Integration for the Department of Medicine. She has been recognized as a fellow of the American College of Gastroenterology (ACG) and serves on the Women in GI Committee and was former member of the Board of Governors (Michigan). She is active in the Crohn’s and Colitis Foundation and currently is the Co-Chair for the Women in IBD Task Force and member of the Government and Industry Affairs Committee for the National Scientific Advisory Committee. She is currently acting Co-Chair and Founder of the Michigan Gastrointestinal Society. 

Dr. Kinnucan is nationally known in the field of gastroenterology, in particular her specialization in evaluation and management of patients with IBD. She is known to the Twitter world as @ibdgijami and uses the platform to raise awareness and improve education related to gastroenterology, IBD and promotion of women in medicine and GI. She is lead author and co-author of articles in numerous peer-reviewed medical journals, she has written several book chapters about IBD diagnostics and treatments. Her most recent research focus has been to evaluate the role for cannabis in the treatment of IBD related symptoms. 

Classification and Management of Pouch Disorders

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

Ed Barnes

UNC School of Medicine

Jami Kinnucan

Mayo Clinic, Florida

Uma Mahadevan-min

Uma Mahadevan

UCSF Colitis and Crohn’s Disease Center

Dr. Uma Mahadevan is a gastroenterologist and clinical scientist specializing in inflammatory bowel disease (IBD), particularly pregnancy and drug safety. She completed a medical degree at the State University of New York in Brooklyn, residency in internal medicine at Mount Sinai Medical Center in New York, and a fellowship in gastroenterology at the University of California, San Francisco (UCSF). She did an advanced fellowship in IBD at the Mayo Clinic, Rochester, Minnesota. Dr. Mahadevan currently serves as Professor of Medicine at UCSF, Director of the UCSF Colitis and Crohn’s Disease Center and Director of the Advanced IBD Fellowship. For her exceptional work in pregnancy and drug safety and her mentoring of GI fellows and junior faculty she received the AGA 2022 Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Research Mentor Award and the 2022 Sherman Prize.

Certified by the American Board of Internal Medicine as a Diplomate in internal medicine and gastroenterology, Dr. Mahadevan is a fellow of the American Gastroenterological Association, for whom she was Chair for the IMIBD Section, Chair of the AGA National IBD Parenthood initiative and Director (2023) and co-Director (2022, 2017) of the AGA Postgraduate Course. She is a Fellow of the American College of Gastroenterology and served on the Educational Affairs Committee and as a member of the Advanced IBD Fellow Curriculum Committee.  She was Chair of the Crohns Colitis Foundation Clinical Research Grants committee, a member of the National Scientific Advisory Committee and Taskforce on Women in IBD, and co-chair of the annual Crohn’s Colitis Congress (2020). 

Dr. Mahadevan has served on many prestigious journals, including special section editor for Gastroenterology.  Dr. Mahadevan has published over 100 original articles, abstracts, editorials, and invited reviews in such peer-reviewed journals as Gastroenterology, Gut, Nature Reviews, American Journal of Gastroenterology, Inflammatory Bowel Diseases, and Lancet Gastroenterology Hepatology as well as several book chapters.  She authored the joint AGA, Society of Maternal Fetal Medicine Clinical Care Pathway on the Management of IBD in Pregnancy.

Dr. Mahadevan specializes in the treatment of complex ulcerative colitis and Crohn’s disease. She is a global expert on the management of pregnancy and drug safety in the patient with IBD. She is also interested in the role of diet and IBD and has an ongoing original study in this area. Her current projects include a national prospective registry of pregnancy outcomes and drug safety in women with IBD on immunosuppressive and biologic medications (PIANO), clinical trials in biologic therapy for IBD, and the impact of nutritional interventions in the management of IBD (SEAMUS). She has an interest in digital health and lead the transition of the GI Division to telemedicine at the start of the pandemic in March 2020 and has developed an IBD Chatbot with the Center for Digital Health and Innovation at UCSF. This IBD Chat can remotely monitor thousands of patients with IBD and integrate with the existing electronic health record. Additionally, in collaboration with data scientists at UCSF, she is studying ways to answer important questions in IBD using the UCSF electronic health record. 

Dr. Mahadevan is proud to have mentored several Advanced IBD Fellows who know hold key roles in IBD Centers around the United States.

Sonia Friedman

Sonia Friedman

BWH Crohn’s & Colitis Center

Sonia Friedman, M.D. will join Tufts Medical Center in Boston as Chief of Gastroenterology in March 2023. She has spent the past 23 years at Brigham and Women’s Hospital in Boston where she was a Professor of Medicine at Harvard Medical School. Dr. Friedman completed her undergraduate degree in biology at Stanford University and her MD at Yale Medical School. She did her medical internship and residency at University of Pennsylvania and her gastroenterology fellowship at Mount Sinai Medical Center in New York City. She has received national and international recognition for research and treatment of inflammatory bowel disease. Her research interests include reproductive health and the safety of medications taking during conception and/or during pregnancy in patients with inflammatory bowel disease. Dr. Friedman is a frequent speaker and invited regional, national and international lecturer on the management of inflammatory bowel disease. She has authored or co-authored multiple peer-reviewed papers and is the Deputy Editor of the journal Inflammatory Bowel Diseases. She has received a recent Crohn’s and Colitis Foundation Senior Research Award as well as an American College of Gastroenterology Clinical Research Award to continue her work on reproductive health in inflammatory bowel disease.

Women’s Health in IBD: Preconception to Menopause

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

Uma Mahadevan

UCSF Colitis and Crohn’s Disease Center

Sonia Friedman

BWH Crohn’s & Colitis Center

Freddy Caldera-min

Freddy Caldera

University of Wisconsin School of Medicine and Public Health

Dr. Caldera is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at University of Wisconsin-Madison School of Medicine and Public Health.    He completed his internal medicine residency and fellowship at University of Kentucky.  He has completed a Master’s in Clinical Investigation and is finishing his PhD at University of Wisconsin School of Medicine and Public Health.  He is physician-scientist whose research interest is evaluating the immune response to vaccines in patients with IBD and the risk of vaccine preventable disease in patients with IBD.   He has a collaborative lab (Caldera-Hayney Lab) whose focus is evaluating immune response to vaccine in immunosuppressed patients. 

Neil Hyman

Neil Hyman

University of Chicago

Dr. Hyman is Professor of Surgery, and Chief of the Section of Colon and Rectal Surgery at the University of Chicago Medicine.  He has authored more than 250 peer-reviewed original articles or textbook chapters.

He is Past President of the American Society of Colon and Rectal Surgeons, Director of the American Board of Colon and Rectal Surgery, and Associate Editor of the Annals of Surgery and Journal of Gastrointestinal Surgery.

Parambir Dulai

Parambir Dulai

Northwestern Medicine

Parambir S. Dulai, MD, is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Northwestern University. He serves as the Director of GI Clinical Trials and Precision Medicine. He completed his internal medicine residency and chief residency at Dartmouth, and subsequently completed an NIH T32 research fellowship at University of California San Diego followed by an IBD Clinical Fellowship. He went on to complete a clinical trials fellowship at Robarts Clinical Trials. He has a robust research program focusing on pragmatic clinical trials and biomarker discovery, and his NIH funded lab focuses on emerging approaches to studying spatial biology in immune mediated inflammatory diseases. 

Frank Farraye

Mayo Clinic, Florida

Francis A. Farraye, MD, MSc is Director of the Inflammatory Bowel Disease Center in the Division of Gastroenterology and Hepatology and Professor of Medicine at the Mayo Clinic in Jacksonville, FL. He received his MD from Albert Einstein College of Medicine in New York. He completed an internal medicine residency and gastroenterology fellowship at the Beth Israel Hospital in Boston and a Master’s Degree in Epidemiology from the Harvard School of Public Health. Dr. Farraye has an active academic clinical practice managing patients with Inflammatory Bowel Disease. A frequent speaker and invited lecturer on topics on the diagnosis and management of inflammatory bowel disease, Dr. Farraye has authored or co-authored over 450 original scientific manuscripts, chapters, reviews, and abstracts. He is the series editor for the text Curbside Consultation in Gastroenterology and co-wrote the text, Curbside Consultation in Inflammatory Bowel Disease and Gastrointestinal Emergencies. His newest book for patients is Mayo Clinic on Crohn’s Disease and Ulcerative Colitis. He is the Editor in Chief for Inflammatory Bowel Disease Journal Scan published weekly by the ASGE. Dr. Farraye is a Fellow in the ASGE and AGA, and a Master of the American College of Gastroenterology. He has served on numerous national and international committees. The New England Crohn’s and Colitis Foundation named Dr. Farraye Humanitarian of the Year in 2003. In 2009, the ACG awarded Dr. Farraye the William Carey Award for service to the college. In 2020, Dr. Farraye was a recipient of the Lifetime Achievement Award from the New England Crohn’s and Colitis Foundation. 

Health Maintenance in IBD

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

Frank Farraye

Mayo Clinic, Florida

Freddy Caldera

University of Wisconsin School of Medicine and Public Health

Medical & Surgical Approaches in Patients with Acute Severe Colitis

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

Neil Hyman

University of Chicago

Parambir Dulai

Northwestern Medicine

Samir Shah

Samir Shah

Brown University

Samir A. Shah, MD, FACG, is a Clinical Professor of Medicine at the Alpert Medical School of Brown University, Chief of Gastroenterology at the Miriam Hospital, and a partner with Gastroenterology Associates Inc in Providence, RI. Dr. Shah earned his BA in Biochemistry magna cum laude at Brown, and his MD at Harvard Medical School in Boston, MA. He did a residency in Internal Medicine at the Harvard-affiliated Beth Israel Deaconess Medical Center and stayed on for a fellowship in Gastroenterology, where he was awarded a Howard Hughes Postdoctoral Fellowship for Physicians and spent two years in the laboratory studying murine models of Inflammatory Bowel Disease. Dr. Shah is the recipient of Brown University’s Teaching Recognition Award, The Dean’s Teaching Excellence Certificate, Brown University’s Excellence in Teaching Award for Clinical Faculty, the Beckwith Family Award for Outstanding Teaching, the ACG’s Freshman Governor’s Award, and the William D. Carey Award. The New England Chapter of the Crohn’s and Colitis Foundation of America named him Humanitarian of the Year for 2009 and co-recipient of the Joan Cutler Lifetime achievement award in 2020. In 2023, he recieved the Lifetime Achievement Award from the DDNC. Rhode Island Monthly magazine consistently names him among the Top Doctors in Rhode Island. He serves as the Physician Lead for his groups’ participation in IBD QORUS, is a Past President of the Digestive Diseases National Coalition (DDNC), faculty for the ACG’s online IBD Circle, and Immediate Past President of the ACG. He has participated in several multi-center clinical trials of cutting-edge therapies for IBD and was co-principal investigator for OSCCAR (Ocean State Crohn’s and Colitis Area Registry).

kofi clarke

Kofi Clarke

Penn State College of Medicine

Kofi Clarke is a Professor of Medicine and serves as Chief of the Division of Gastroenterology and Hepatology at Penn State Hershey College of Medicine.  He is also The Graham H Jeffries Endowed Professor of Medicine 

He completed post graduate training in medicine and gastroenterology in England, residency, chief residency, and fellowship in Pittsburgh. He also completed a research methods fellowship at Michigan State University. His clinical and research interests are in luminal bowel disease- primarily Inflammatory Bowel Disease and Celiac Disease and is active in Graduate Medical education.

He has contributed to several peer reviewed manuscripts, abstracts, a book chapter, and is the Principal Investigator of several multicenter clinical trials at Penn State Health Division of Gastroenterology and Hepatology.

Dysplasia Surveillance in Chronic Colitis: Who, when, how, and how often?

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

Samir Shah

Brown University

Kofi Clarke

Penn State College of Medicine

Miguel Regueiro, MD -min

Miguel Regueiro

Cleveland Clinic

Dr. Regueiro is the Chair of the Digestive Disease and Surgery Institute at Cleveland Clinic, and Professor in the Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.  

Dr. Regueiro’s main clinical and research interest is Inflammatory Bowel Diseases (IBD) with a focus on the natural course of Crohn’s disease and ulcerative colitis.  He leads research on postoperative prevention of Crohn’s disease, as well as developing new models of healthcare, including the first-of-its kind specialty medical home for IBD. 

Oriana Damas-min (1)

Oriana Damas

University of Miami Health System

Oriana M. Damas, MD, MSCTI is an Assistant Professor of Medicine at the University of Miami Crohn’s and Colitis Center in the Division of Gastroenterology and the Director of Translational Studies for the Center. She is an IBD clinician and also a physician scientist. Her NIH-funded research delves into understanding environmental and dietary patterns that can influence development of disease and modify disease outcomes.  Her current NIH NIDDK K23 award that focuses on understanding dietary, genetic and microbiome factors that lead to gut inflammation in Hispanics, which represent an emerging population of IBD.  

Post Operative Crohn’s Disease

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

Miguel Regueiro

Cleveland Clinic

Oriana Damas

University of Miami Health System

Alan-Moss-MD-Gastroenterology

Alan C. Moss

Boston Medical Centre, Massachusetts

Alan C Moss MD, FACG, FEBG, AGAF, FRCPI

Current Academic / Administrative Roles
Director, Crohn’s & Colitis Program, Boston Medical Center
Professor of Medicine, Boston University School of Medicine
Interim Chief, Gastroenterology Section, Boston Medical Center

Education

  • Medical School – Royal College of Surgeons in Ireland 1997
  • Medical Doctorate (by research) – University College Dublin, 2002-2004

Prior Academic / Administrative Roles

  • Associate Professor of Medicine, Harvard Medical School
  • Gastroenterologist, Beth Israel Deaconess Medical Center (BIDMC)
  • Director of Translational Research, IBD Center, BIDMC
  • Director of IBD Fellowship, BIDMC

Key Honors & Awards

  • Fellow of the American College of Gastroenterology, American Gastroenterology Association,
    European Board of Gastroenterology, and Royal College of Physicians
  • Goldwitz-Allen Memorial Lectureship, State University of New York
  • Keynote Speaker, Translational Microbiome Research Summit, Microbiome Center at MIT
  • Visiting Professor; University College Dublin, University of Barcelona, Trinity College School of
    Medicine
  • Humanitarian of the Year, Crohn’s & Colitis Foundation, New England Chapter

Key National / International Committees

  • National Immunology & Inflammatory Bowel Diseases Section, AGA Institute Council (2012-2014)
  • Pilot Study Steering Committee, CCFA Clinical Research Alliance
  • National Professional Education Committee, Crohn’s & Colitis Foundation
  • Planning Committee, AGA Freston Conference on Microbiome Therapy (2016)
  • Advisory Committee, NIH Common Fund Extracellular RNA Communication Program (2017)
  • National Scientific Advisory Committee, Crohn’s & Colitis Foundation

Key International Editorial Roles

  • Deputy Editor; Crohn’s & Colitis 360 (Crohn’s & Colitis Foundation)
  • Associate Editor; Journal of Crohn’s & Colitis (ECCO), Frontline Gastroenterology (BMJ), World
    Journal of Gastroenterology
  • Peer Reviewer; NEJM, JAMA, Gastroenterology, BMJ, Gastroenterology, Gut, Am J Gastroenterology
  • Grant Reviewer; NIH, Broad Medical Research Foundation, Netherlands Organization for Research,
    Israel Science Foundation, European Research Council
  • Section Head (GI disease); New England Journal of Medicine Knowledge Plus

Academic Publications Summary

  • Over 200 peer-reviewed papers, cited by over 2000 independent papers (h-index : 28)
  • Published research in; Gut, Clinical Gastroenterology & Hepatology, American Journal of
    Gastroenterology, Inflammatory Bowel Diseases, European Journal of Immunology, J Crohn’s & Colitis

Grant Funding History

  • Federal – NIDDK
  • Foundations – Helmsley Charitable Trust, AGA Foundation, Crohn’s & Colitis Foundation
  • Industry – Pfizer, Takeda

Positioning Highly Effective Therapy in CD

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

Alan C. Moss

Boston Medical Centre, Massachusetts

Meena Bewtra

Penn Medicine

Lisa Malter

Lisa Malter

NYU Grossman School of Medicine

Lisa Malter, MD, FACG, AGAF is a Professor of Medicine at the NYU School of Medicine, the Director of Education for the NYU IBD Center and Director of the Inflammatory Bowel Disease Clinic at the Bellevue Hospital Center in New York City. Board-certified in Gastroenterology, Dr. Malter’s patient practice is focused primarily on inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, and she has pioneered access to care for the underserved patient population at Bellevue. Dr. Malter’s academic interests include the study of inflammatory bowel disease, patient safety, and fellowship education. Dr. Malter teaches at the NYU Grossman School of Medicine and has published in the Journal of Clinical Gastroenterology, Inflammatory Bowel Diseases, and The American Journal of Gastroenterology. She is a member of ACG, AGA, and the Crohn’s and Colitis Foundation. She created the IBD 101 First -Year Fellows course pioneering the use of standardized patients in IBD education. She serves as an Associate editor of the ACG Universe and CC360, is a member of the ACG Public Relations Committee, the ACG Education Committee, the Crohn’s and Colitis Foundation’s Professional Education Committee, the Crohn’s and Colitis Foundation’s Women in IBD Task Force and as a faculty advisor for the Foundation’s Great New York Fellows’ Education Committee. Dr. Malter received her medical degree from Rosalind Franklin University/Chicago Medical School, completed her internal medicine internship and residency at The Mount Sinai Hospital in New York, and went on to complete a Gastroenterology fellowship at NYU Langone Medical Center.

Positioning Highly Effective Therapy in UC

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

Gary Lichtenstein

Penn Medicine

Lisa Malter

NYU Grossman School of Medicine

Florian Rieder, MD 2

Florian Rieder

Cleveland Clinic

Dr. Rieder is Vice Chair, Co-Director of the IBD section, Director of IBD research and Director of the Advanced IBD Fellowship program at the Department of Gastroenterology, Hepatology and Nutrition at the Cleveland Clinic, Cleveland. His clinical focus is patients with IBD with a special emphasis on the field of pathogenesis, prediction and therapy of intestinal fibrosis. Dr. Rieder has published more than 150 articles and book chapters and has been recognized for his expertise as indicated through invitations to clinical guideline steering committees of the European Crohn’s and Colitis Organization (ECCO). He is lead author of the ECCO guidelines on Ulcerative colitis and lead author of the first ECCO clinical consensus on ‘Diagnosis and Management of Intestinal Fibrosis’. He received multiple international invitations as a speaker, session chair or conference faculty. Dr. Rieder serves as an abstract reviewer for all major GI conferences, he is past associate editor (Clinical and Translational Gastroenterology) and on several editorial boards of medical journals. He is proud of his significant ties to the ECCO, which he served as the chair of Y-ECCO, member of the ECCO operational board, prior Y-ECCO committee member and member of the scientific committee.  He is past chair of REACH-IBD and Co-Chair of the Professional Education Committee of the Crohn’s and Colitis Foundation. Dr. Rieder is the leading PI on the international Stenosis Therapy and Research (STAR) Consortium with the goal to build a pathway to test anti-fibrotic medications in stricturing Crohn’s disease and was recently awarded the Sherman Emerging Leaders award.

Kara De Felice

Kara De Felice

University of Cincinnati

Dr. De Felice is an Associate Professor of Clinical Medicine and the Director of Inflammatory Bowel Diseases at the University of Cincinnati. She is currently building a multidisciplinary IBD Center with the goal to provide excellent IBD patient care, improve patient outcomes, participate in research, and train the next generation of gastroenterologists. She loves to travel, play tennis, watch football, have dinner and cocktails parties. 

 

Classification and Management of Extraintestinal Manifestations

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

Florian Rieder, MD

Florian Rieder

Cleveland Clinic

Kara De Felice

University of Cincinnati

Steve Hanauer

Steve Hanauer

Northwestern University



Stephen B. Hanauer, MD, FACG, is Internationally recognized expert on the treatment of inflammatory bowel disease (IBD) and advisor on the development of multiple leading IBD drugs. He is a board-certified internist and gastroenterologist and prior to joining Northwestern University’s Feinberg School of Medicine as  the Clifford Joseph Barborka Professor of Medicine and Medical Director of the Digestive Health Center at Northwestern University’s Feinberg School of Medicine Dr. Hanauer was the Joseph B. Kirsner Professor and Chief of Gastroenterology, Hepatology and Nutrition at the University of Chicago. Dr. Hanauer is a Master and past President of the American College of Gastroenterology (ACG) and the former Chair of the American Gastroenterological Association’s Inflammation, Immunology, and IBD Section as well as the Clinical Practice chair. He is also a prior member of the Gastroenterology Specialty Board of the American Board of Internal Medicine and is a member and former-Chairman of the International Organization for Inflammatory Bowel Disease. Among his many honors, Dr. Hanauer received the AGA’s Fiterman Foundation Joseph B. Kirsner Award for Clinical Research in Gastroenterology and the AGA’s Janssen Award for Clinical Excellence.  He also received awards from the ACG for Clinical excellence and clinical research.  He has served as     a member of the U.S. FDA Gastrointestinal Drugs Advisory Committee since 1987,  Chaired the Committee from 1998-2000, and has served the Center for Drug Development and Research as a Special Consultant defining new guidelines for clinical evaluation of IBD patients. In 2020, he received the “Great Teachers” Award from the National Institute of Health (NIH). In 2021, he received the Mentoring Award from ACG and previously from the American Medical Association. Dr. Hanauer has expertise in designing and leading clinical studies for IBD related therapies and has acted as a clinical investigator and/or advisor to pharmaceutical companies in the development of many leading IBD therapies. Dr. Hanauer has authored over 475 peer-reviewed journal articles and numerous books and book chapters, abstracts, monographs, and editorials.



Marla Dubinsky-min

Marla Dubinsky

Icahn School Of Medicine, Mount Sinai, New York

Marla C. Dubinsky, MD, is a Professor of Pediatrics and Medicine at the Icahn School of Medicine at Mount Sinai, New York, NY. Dr. Dubinsky received her medical degree from Queen’s University, Canada. She completed her pediatric residency at Alberta Children’s Hospital, Calgary, Canada, and her clinical fellowship in gastroenterology and nutrition at Sainte-Justine Hospital at the University of Montreal, Canada. She completed her research fellowship in IBD at Cedars-Sinai Medical Center in Los Angeles, CA, where she served as the Director of the Pediatric IBD Center before going to Mount Sinai as the Chief of Pediatric Gastroenterology and Nutrition at the Mount Sinai Kravis Children’s Hospital and Co-Director of the Susan and Leonard Feinstein IBD Clinical Center.  Dr. Dubinsky is also the Co-Director of the IBD Preconception and Pregnancy Planning Clinic at Mount Sinai. She is the Co-Founder of Mi-Test Health, and Cornerstones Health which is a non-profit organization dedicated to enhancing and transforming communication between health care providers, patients, and industry partners through creative, comprehensive, and expert-based educational program. She is also the Co-Founder of Trellus Health, a resilience driven connected health solution for chronic conditions.  

Dr. Dubinsky has been engaged in inflammatory bowel disease (IBD) clinical and translational research for over two decades. Dr. Dubinsky’s primary research focuses on developing predictive models and web-based decision support tools that integrate clinical and biomarkers to predict the natural history of IBD and response to therapy. She has a keen interest in personalized medicine in IBD and her research uncovers predictors of rapid disease progression with the goal of preventing complications by altering treatment plans. Dr. Dubinsky is the principal investigator of multiple large longitudinal cohorts including the Road to Prevention Multiplex Family Program at Mount Sinai with over 700 enrolled participants with a goal of using multi-omic data to predict the development of IBD in unaffected family members and co-investigator of the Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children with Crohn’s Disease (RISK) study and senior author on the manuscript presenting a model to predict the natural history of pediatric Crohn’s disease. Dr. Dubinsky is very committed to women’s reproductive health in IBD and in addition to her research in this field she is the Co-founder of WECARE in IBD, an organization dedicated to the health of women with IBD. She has lectured widely, both nationally and internationally, and has published in more than 260 peer-reviewed journals, including Gastroenterology, Lancet, JAMA, The Journal of Pediatric Gastroenterology and Nutrition, The journal of Crohn’s and Colitis, Inflammatory Bowel Diseases, and the American Journal of Gastroenterology.

Treat to Target and Therapeutic Monitoring in IBD

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

Marla Dubinsky-min

Marla Dubinsky

Icahn School Of Medicine, Mount Sinai, New York

Steve Hanauer

Northwestern University

Corey Siegel

The Dartmouth Institute for Health

Corey A. Siegel, MD, MS, is the Section Chief of Gastroenterology and Hepatology and the Co-Director of the Inflammatory Bowel Disease (IBD) Center at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. He is the Constantine and Joyce Hampers Professor of Medicine and a Professor at The Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth.

Dr. Siegel attended college at Tufts University and then received his medical degree from Tufts University School of Medicine in Boston, Massachusetts. He completed his residency in internal medicine at the Dartmouth Hitchcock Medical Center where he also served as chief medical resident. He then completed a fellowship in Gastroenterology at Dartmouth Hitchcock followed by a fellowship in Inflammatory Bowel Disease at Massachusetts General Hospital in Boston. 

Dr. Siegel’s research interests include understanding risk/benefit tradeoffs in IBD, developing models to predict outcomes in Crohn’s disease, creating tools to facilitate shared decision making, expanding telemedicine services to patients with IBD living in rural locations, and improving the quality of care delivered to patients with IBD. He has been funded by the NIH, AHRQ, the Crohn’s and Colitis Foundation, and the Leona M. and Harry B. Helmsley Charitable Trust for this work.  He has lectured nationally and internationally and published numerous journal articles and book chapters on this and other topics in IBD. Dr. Siegel is the founder of the BRIDGe group, an international research collaborative of IBD investigators.  He is currently the co-chair of the Crohn’s and Colitis Foundation Quality of Care Program (IBD Qorus). Dr. Siegel was inducted into the International Organization for the Study of IBD (IOIBD) in 2013. He lives in Hanover, New Hampshire with his wife and three boys.

kim-isaacs

Kim Isaacs

Vanderbilt IBD Clinic

Kim Isaacs MD PhD is Professor of Medicine in the Division of Gastroenterology and Hepatology at the University of North Carolina @ Chapel Hill.  She completed her residency and gastroenterology fellowship at the University of North Carolina.  She was past co-director of the Inflammatory Bowel Disease Center at the University of North Carolina and director of outpatient endoscopy at UNC.   She has been principal investigator in numerous clinical trials in inflammatory bowel disease.   She has been involved in recent guideline development in ulcerative colitis and Crohn’s disease. 

bharati kochar

Bharati Kochar

Cleveland Clinic

Bharati Kochar is a gastroenterologist and inflammatory bowel disease (IBD) specialist at the Massachusetts General Hospital, Investigator at The Mongan Institute and Assistant Professor of Medicine at Harvard Medical School. After medical school at Brown University, she trained in Internal Medicine at the Johns Hopkins Hospital and did a GI fellowship as well as advanced fellowship in IBD at the University of North Carolina. She also obtained a Master’s of Science in Clinical Research at UNC’s Gillings School of Global Public Health. Dr. Kochar’s research program is interested in advancing the care and quality of life for under-served and under-studied patients with IBD, including older adults. She is funded by the Crohn’s and Colitis Foundation as well as the National Institute of Aging. 

Management of Refractory and Complicated Crohn's Disease

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

Corey Siegel

Corey Siegel

The Dartmouth Institute for Health

Kim Isaacs

UNC School of Medicine

Managing IBD from Pediatrics to the Elderly

Raymond Cross, MD

University of Maryland

Millie D. Long, MD

UNC School of Medicine

bharati kochar

Bharati Kochar

Massachusetts General Hospital

Mike Rosen

Stanford University